Editor's Correspondence |

Lipid Levels and Estrogen Replacement Therapy in Postmenopausal Women

Jose Ness, MD; Cynthia X. Pan, MD
Arch Intern Med. 1999;159(9):1013. doi:.
Text Size: A A A
Published online


The article in the ARCHIVES by Weintraub and colleagues1 contends that fluctuations in the levels of lipids should be taken into account when monitoring postmenopausal women receiving combined sequential estrogen replacement therapy (ERT) for hypercholesterolemia. They justify the importance of such monitoring with the statement that "ERT is associated with a 50% reduction in the incidence of coronary artery disease(CAD)."1 While this statement might have been well founded at the time of submission of the paper, new scientific evidence has surfaced since then that sheds a different light on the role of estrogen in the treatment of ischemic heart disease. The Heart and Estrogen/ Progestin Replacement Study (HERS) trial recently published in JAMA2 has shown under randomized placebo controlled double-blind conditions that ERT did not decrease the incidence of coronary heart disease events (nonfatal myocardial infarction or coronary heart disease death) in a large number of postmenopausal women followed for an average of 4.1 years. In fact, there was increased mortality associated with ERT in the first year of the trial, later compensated by a decreased death rate in years 4 and 5. The authors of the HERS trial state that the "lack of an overall effect occurred despite a net 11% lower low-density lipoprotein cholesterol level and 10% higher high-density lipoprotein cholesterol level in the hormone group compared with the placebo group."2 Therefore, at the moment the usefulness of estrogen/progestin in the management of coronary artery disease is being seriously questioned.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Table 9.2-3 Refuted Evidence From Observational Studiesa